Investor Relations

Here you find financial information to facilitate the assessment of ChromoGenics as placement.

Investor Relations task is to continuously provide the capital market with information about ChromoGenics operation and financial development. Please contact us if you have questions or comments.

IR contact

Susanne Andersson
CFO & Head of Communications
+46 730 66 8904
Email

  • co-fin-emh_logotyp

Subscribe

Subscribe to our news